Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy.

Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy. Abstract Text:

    marc bischofMarc Bischof, debus Debus,klaus herfarthKlaus Herfarth,thomas muleyThomas Muley,jutta kappesJutta Kappes,konstantina storzKonstantina Storz,hans hoffmannHans Hoffmann,

    PURPOSE: To analyze the effectiveness of surgery and chemotherapy with or without radiotherapy in the management of limited small cell lung cancer (LSCLC) in stages I and II. PATIENTS AND METHODS: 39 patients (median age 62 years) with LSCLC in stages pT1 or pT2 and pN0 or pN1 (stages IA-IIB) who had a tumor resection and systematic lymph node dissection were reviewed retrospectively. The median follow-up period was 29 months. 35 patients (90%) received a median of four cycles of a platinum-containing chemotherapy postoperatively. 16 patients (41%) received an adjuvant thoracic radiotherapy (TRT, median 50 Gy); 21 patients (54%) received a prophylactic cranial irradiation (PCI, median 30 Gy). RESULTS: The median overall survival for all patients was 47 months, resulting in actuarial 1-, 3-, and 5-year survival rates of 97%, 58%, and 49%, respectively. Distant metastases were found in 13 patients (33%) after a median of 16 months. Patients who received an adjuvant TRT showed a trend toward improved thoracic recurrence-free survival (p = 0.06) and improved overall survival (p = 0.07) compared to those treated with surgery and chemotherapy only. Brain metastasis-free survival (p = 0.01) and overall survival (p = 0.01) were improved significantly in patients who received a PCI. CONCLUSION: Surgical tumor resection may be considered for carefully selected patients. Adjuvant chemotherapy and PCI are recommended for all patients. Adjuvant TRT is currently used in patients with positive lymph nodes (pN1), because the probability of a subclinical involvement of the mediastinal lymphatic system appears to be increased in these patients.

    Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy. Publishing Authors By Initials

    m bischofM Bischof,j debusJ Debus,k herfarthK Herfarth,t muleyT Muley,j kappesJ Kappes,k storzK Storz,h hoffmannH Hoffmann,

    For similar investigative techniques: epidemiologic methods: statistics as topic: survival analysis research abstracts see: investigative techniques: epidemiologic methods: statistics as topic: survival analysis research

    PUBMED ID PMID:

    MEDLINE DATE:

    Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Strahlentherapie und Onkologie : Organ der Deutsch

    VOLUME: 183

    Page Numbers: 679-84

    Journal Abbreviation:

    ISSN: 0179-7158

    DAY: 11

    MONTH: Dec

    YEAR: 2007

    Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8603469

    Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy. Keywords Mesh Terms:

    KEYWORDS: Survival Analysis

    MESH TERMS: administration & dosage

    Chemical & Substance for Abstract: Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy. Information

    Substance Name: Organoplatinum Compounds

    Registry Number: 0

    Grant and Affiliation Information for Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy.

    AFFILIATION: Department of Radiooncology, University of Heidelberg, Germany. marc_bischof@med.uni-heidelberg.de

    Country: Germany

    Germany Research PublicationGermany Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Strahlenther Onkol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News